Literature DB >> 3399894

Low plasma cholesterol levels caused by a short deletion in the apolipoprotein B gene.

S G Young1, S T Northey, B J McCarthy.   

Abstract

Familial hypobetalipoproteinemia is a syndrome in which the plasma levels of apolipoprotein B (apo-B) and cholesterol are abnormally low. A truncated species of apo-B was identified in the plasma lipoproteins of members of a kindred with familial hypobetalipoproteinemia. DNA sequencing studies on genomic clones and enzymatically amplified genomic DNA samples revealed a four-base pair deletion in the apo-B gene. This short deletion, which results in a frameshift and a premature stop codon, accounts for the truncated apo-B species and explains the low apo-B and low cholesterol levels in this family.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3399894     DOI: 10.1126/science.3399894

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  12 in total

Review 1.  Genetic basis of lipoprotein disorders.

Authors:  J L Breslow
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

2.  Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.

Authors:  S G Young; S T Hubl; R S Smith; S M Snyder; J F Terdiman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 3.  CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.

Authors:  Alexandra C Chadwick; Kiran Musunuru
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-24       Impact factor: 8.311

4.  Transcriptional regulation of the apolipoprotein B100 gene: purification and characterization of trans-acting factor BRF-2.

Authors:  H Zhuang; S S Chuang; H K Das
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

5.  Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia.

Authors:  D A Hardman; C R Pullinger; R L Hamilton; J P Kane; M J Malloy
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Exclusion of linkage between the human apolipoprotein B gene and abetalipoproteinemia.

Authors:  L S Huang; P A Jänne; J de Graaf; M Cooper; R J Deckelbaum; H Kayden; J L Breslow; R J Decklebaum
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

7.  The human apolipoprotein B 3' hypervariable region: detection of eight new alleles and comparisons of allele frequencies in blacks and whites.

Authors:  J E Hixson; P K Powers; C A McMahan
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

8.  Reading-frame restoration with an apolipoprotein B gene frameshift mutation.

Authors:  M F Linton; V Pierotti; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

9.  Heterogeneity of molecular weight and apolipoproteins in low density lipoproteins of healthy human males.

Authors:  T S Kahlon; V G Shore; F T Lindgren
Journal:  Lipids       Date:  1992-12       Impact factor: 1.880

10.  An Infant with Chronic Diarrhoea and Failure to Thrive: Familial Hypobetalipoproteinemia.

Authors:  Ankur Singh; Rajniti Prasad; Om Prakash Mishra
Journal:  J Clin Diagn Res       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.